Reference pricing, competition, and pharmaceutical expenditures: Theory and evidence from a natural experiment
-
Why orphan drug coverage reimbursement decision-makingneeds patient and public involvement
Pharma Live, , Intellectual Property Rights, 0
1-s2-0-s0168851015000123-mainDownload
-
What Is Wrong with Orphan Drug Policies?
Pharma Live, , Intellectual Property Rights, 0
1-s2-0-s1098301512041290-mainDownload
-
How to apply a patent in European Patent Office (EPO) ?
Pharma Live, , Intellectual Property Rights, 0
How long does a granted patent stay valid? The maximum term of a European patent is 20 years from...
-
Federal Circuit Says Regulatory Patent Term Extension Prolongs Life of Entire Patent – Courtesy(Pharma Patents)
Pharma Live, , Intellectual Property Rights, 0
POSTED BY COURTENAY C. BRINCKERHOFF ON 3 NOVEMBER 2011POSTED IN FEDERAL CIRCUIT DECISIONS;PATENT TERM EXTENSIONI wrote previously about the patentability issues raised in Genetics Institute,...
-
Court Denies Generic Drug Manufacturer’s Motion to Dismiss Hatch-Waxman Patent Infringement Action on Jurisdiction Grounds
Pharma Live, , Intellectual Property Rights, 0
the United States District Court for the Southern District of Indiana joined the District of Delaware and Eastern District...
-
Court Cites Objects Of Invention In Claim Construction – Courtesy (Pharma Patents)
Pharma Live, , Intellectual Property Rights, 0
POSTED BY COURTENAY C. BRINCKERHOFF ON 24 FEBRUARY 2015POSTED IN CLAIM CONSTRUCTION;FEDERAL CIRCUIT DECISIONSPacing Technologies, LLC v. Garmin International, Inc. is one of...
-
Orphan drug market to reach $176bn by 2020 – Courtesy ( PMLiVe)
Pharma Live, , Intellectual Property Rights, 0
pharmacistThe global orphan drug market is expected to account for 19% of all branded prescription drug sales by 2020,...
-
Comparing first level patent data with value-added patent information: A case study in the pharmaceutical field q
Pharma Live, , Intellectual Property Rights, 0
1-s2-0-s0172219008000823-mainDownload